-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
November 01, 2021 - therapies. … , digital gamified cognitive
therapies, EndeavorRx, play therapy, play-based
interventions, mindfulness-based … ): Specific treatments compared with
other treatments as described above or to no treatment
KQ 3 (monitoring … Therapies"[MeSH] OR "Combined Modality Therapy"[MeSH]
ADHD Systematic Review Protocol … ] OR "alternative therapy"[tiab] OR "alternative therapies"[tiab]
OR "Interpersonal skills training"
-
effectivehealthcare.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
February 01, 2008 - is contraindicated; failure of
anticoagulant therapy in thromboembolic diseases;
emergency treatment … is contraindicated; failure of
anticoagulant therapy in thromboembolic diseases;
emergency treatment … is
contraindicated; failure of anticoagulant therapy in
thromboembolic diseases; emergency treatment … is
contraindicated; failure of anticoagulant therapy in
thromboembolic diseases; emergency treatment … and name for IVC filters), mobilization status of the patients, use of
concurrent standard medical therapies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
February 01, 2008 - is contraindicated; failure of
anticoagulant therapy in thromboembolic diseases;
emergency treatment … is contraindicated; failure of
anticoagulant therapy in thromboembolic diseases;
emergency treatment … is
contraindicated; failure of anticoagulant therapy in
thromboembolic diseases; emergency treatment … is
contraindicated; failure of anticoagulant therapy in
thromboembolic diseases; emergency treatment … and name for IVC filters), mobilization status of the patients, use of
concurrent standard medical therapies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/menopause_research-protocol.pdf
March 25, 2012 - have been
studied, in comparison with hormone therapy or placebo, primarily as treatment of vasomotor … Treatments of interest include:
• Hormone therapies
o Oral estrogen only or combined with progestin … “therapy” [Subheading] OR “Therapeutics”[Mesh] OR “Estrogen Replacement
Therapy”[Mesh] OR “Drug Therapy … ”[Mesh] OR “drug therapy” [Subheading] OR “therapeutic
use” [Subheading] OR “Hormone Replacement Therapy … ’/exp OR ‘therapeutics’/exp OR ‘estrogen replacement therapy’/exp OR ‘drug
therapy’/exp OR ‘therapeutic
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
June 01, 2013 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … When these therapies fail to achieve
relief, surgical treatments may be proposed, such as arthroplasty … Current treatments for OA include over-the-counter pain
medication, exercise and/or physical therapy … Autologous MSCs have also been given with
other therapies, including platelet-rich plasma (PRP) therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-13121.pdf
December 05, 2013 - When these therapies fail
to achieve relief, surgical treatments may be proposed, such as arthroplasty … Current treatments for OA include over-the-counter
pain medication, exercise and/or physical therapy … Autologous MSCs have also been given with other therapies,
including platelet-rich plasma (PRP) therapy … of treatments required. … The cost of one PRP
treatment was purported to be lower than the cost of three hyaluronic acid treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-e.xlsx
July 09, 2025 - Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix E Table
Table
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
September 08, 2011 - Rapid diagnosis of sepsis and early initiation of
antibiotic and goal-directed therapies have demonstrated … o Were participants in treatment groups recruited in the same time period? … o Were concurrent/concomitant treatments clearly specified and given
equally to treatment groups? … because they convey the possibility of determining differences in the relative
efficacy of two treatments … Procalcitonin in sepsis and systemic
inflammation: a harmful biomarker and a therapeutic target.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
September 27, 2012 - Treatment Indications
Two major indications for liver-directed therapies exist:
1. … Current Treatments
Several liver-directed therapies have been developed to treat patients with CRC … and harms of the various palliative treatments. … Comparators
KQ 1 & 2:
• All the therapies will be compared to each other as treatment of patients … o Were concurrent/concomitant treatments clearly specified and given equally to
treatment groups?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment_research-protocol.pdf
September 29, 2011 - their therapeutic goal. … In
addition to aggressive medical therapy, two treatment pathways have emerged for treating
patients … Presentation
Treatment
Optimal medical
therapy PCI* CABG*
STEMI X X
NSTEMI/ unstable angina … Adding the effect of different therapies on cognition. … currently in use (such as specific components of treatments
considered to be ―optimal medical therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive-2007.pdf
January 01, 2007 - management era (i.e., since JNC-5 in
19931), what is the evidence on the
effects of aggressive medical therapy … Effectiveness Reviews,
the program supports systematic
appraisals of existing scientific
evidence regarding treatments … What adverse events and complications have
been associated with aggressive medical
therapy or renal artery … Notably, only two trials have compared
angioplasty (without stent placement) with medical
therapy and … alone or medical therapy followed by
angioplasty at 3 months found either no significant
differences
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
June 12, 2013 - have been
studied, in comparison with hormone therapy or placebo, primarily as treatment of vasomotor … Treatments of interest include:
• Hormone therapies
o Oral estrogen only or combined with progestin … “therapy” [Subheading] OR “Therapeutics”[Mesh] OR “Estrogen Replacement
Therapy”[Mesh] OR “Drug Therapy … ”[Mesh] OR “drug therapy” [Subheading] OR “therapeutic
use” [Subheading] OR “Hormone Replacement Therapy … ’/exp OR ‘therapeutics’/exp OR ‘estrogen replacement therapy’/exp OR ‘drug
therapy’/exp OR ‘therapeutic
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
May 01, 2012 - advantage of the incident user design is that it can capture the clinical consequences of an entire
therapeutic … The risk of myocardial infarction associated
with antihypertensive drug therapies. … Adherence to prescribed antihypertensive
drug treatments: longitudinal study of
electronically compiled … Structural accelerated failure time models
for survival analysis in studies with time-
varying treatments … A review of uses
of health care utilization databases for
epidemiologic research on therapeutics.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
January 01, 2014 - Although we are clear throughout that these
are unique diseases with unique treatments, a title
change … Supplemental treatment may include physical
therapy, occupational therapy, and treatment-
related surgery … Supplemental treatment may
include physical therapy, occupational therapy, and
treatment-related surgery … Adjunct treatments. It describes splenectomy as an option for
supportive care. … We
did not investigate any combination therapies for LSDs.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0174_10-20-2009.pdf
January 01, 2009 - devices
Comparator(s): See above interventions and no treatment
Outcome(s): Intermediate outcomes … What is the effectiveness and comparative effectiveness of physical and
rehabilitative treatments available … What are the associated risks, adverse effects, and potential harms of physical and
rehabilitative therapies … There is some indication that
non-pharmacologic therapies are underutilized in patients with OA and … A review
that evaluates the effectiveness of treatments and gaps that remain in the evidence for patient
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
March 05, 2015 - Menopausal Symptoms: Comparative Effectiveness of Therapies. … Major comment 3: The terminology of “hormone therapy” should be
changed to “menopausal hormone therapy … that most times, the authors mean “menopausal hormone therapy”
when they say “hormone therapy.” … Why not include non-medication treatments for menopausal
symptoms in this report? … lines 63 Tamoxifen, alone or in combination with another treatment?
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/improved-cancer-outcomes-protocol_0.pdf
December 01, 2021 - characteristics (cancer type,
treatment type (systemic therapy, radiation, surgery),
stage of disease … cancer diagnosis and initiation of any cancer therapy
(e.g., systemic therapy, radiation, surgery). … (at least in part) w ith cancer therapy (e.g.,
systemic therapy, radiation, surgery), regardless of … (at least in part) w ith cancer
therapy (e.g., systemic therapy, radiation, surgery), regardless of … draft report, the search will be conducted from 2000 to December 2021 to encompass
contemporary cancer treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
November 27, 2012 - In the
former, practitioners move to another therapeutic choice and in the latter,
study subjects drop … Although
therapies may be stopped after 12 to 16
weeks in patients who fail treatment, there
are patients … who are on these therapies
much longer than 16 weeks when therapies
are successful. … Thus, ustekinumab is by far the most convenient therapy. … Amgen has conducted many clinical trials in the
inflammation therapeutic area to demonstrate the safety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d3.xlsx
January 01, 2025 - Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D3 Tables … PSA, Gleason score, T stage, TURP, ADT, abdominal surgery, GI comorbidity, prostate volume, and SV treatment … Seminal vesicle treatment group interaction p-value was statistically significant (p=0.032) but specific … Seminal vesicle treatment group interaction p-value was statistically significant (p=0.032) but specific … NR NR NR NR NR NR NR NR NR 0.96 NR NR NR 0.77 1.2 NR NR 1206 No NR NR Adjusted : Neoadjuvant hormone therapy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_clinician.pdf
September 01, 2014 - Treatments for ASD
focus on improving core deficits in social communication,
addressing challenging … Individual goals for treatment
vary by child, and a combination of therapies is used to
achieve these … ., settings), components of
multicomponent therapies that drive effectiveness, and
predictors of treatment … � Re-evaluating potential treatments as research evolves. … � Available evidence on each program
or therapy.